As of 2024-12-09, the Relative Valuation of Atara Biotherapeutics Inc (ATRA) is (638.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.03 USD, the upside of Atara Biotherapeutics Inc based on Relative Valuation is -4996.8%.
The range of the Relative Valuation is (650.08) - (728.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 28.1x - 45.1x | 34.6x |
Forward P/E multiples | 19.8x - 31.5x | 20.6x |
Fair Price | (650.08) - (728.68) | (638.06) |
Upside | -5089.1% - -5692.3% | -4996.8% |
Date | P/E |
2024-11-25 | -0.52 |
2024-11-22 | -0.50 |
2024-11-21 | -0.46 |
2024-11-20 | -0.46 |
2024-11-19 | -0.48 |
2024-11-18 | -0.49 |
2024-11-15 | -0.52 |
2024-11-14 | -0.55 |
2024-11-13 | -0.62 |
2024-11-12 | -0.50 |
2024-11-11 | -0.51 |
2024-11-08 | -0.49 |
2024-11-07 | -0.44 |
2024-11-06 | -0.43 |
2024-11-05 | -0.44 |
2024-11-04 | -0.50 |
2024-11-01 | -0.42 |
2024-10-31 | -0.39 |
2024-10-30 | -0.41 |
2024-10-29 | -0.38 |
2024-10-28 | -0.38 |
2024-10-25 | -0.37 |
2024-10-24 | -0.37 |
2024-10-23 | -0.37 |
2024-10-22 | -0.39 |
2024-10-21 | -0.40 |
2024-10-18 | -0.41 |
2024-10-17 | -0.41 |
2024-10-16 | -0.40 |
2024-10-15 | -0.36 |
2024-10-14 | -0.35 |
2024-10-11 | -0.35 |
2024-10-10 | -0.34 |
2024-10-09 | -0.34 |
2024-10-08 | -0.34 |
2024-10-07 | -0.33 |
2024-10-04 | -0.33 |
2024-10-03 | -0.31 |
2024-10-02 | -0.33 |
2024-10-01 | -0.33 |
2024-09-30 | -0.35 |
2024-09-27 | -0.35 |
2024-09-26 | -0.33 |
2024-09-25 | -0.32 |
2024-09-24 | -0.33 |
2024-09-23 | -0.32 |
2024-09-20 | -0.34 |
2024-09-19 | -0.34 |
2024-09-18 | -0.34 |
2024-09-17 | -0.37 |